FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.77 $ -0.16 (-3.25 %)    

Monday, 08-Jul-2024 09:33:25 EDT
QQQ $ 496.20 $ -0.33 (-0.07 %)
DIA $ 396.42 $ 2.01 (0.51 %)
SPY $ 555.88 $ 0.98 (0.18 %)
TLT $ 92.37 $ -0.06 (-0.07 %)
GLD $ 219.32 $ -0.32 (-0.15 %)
$ 4.93
$ 4.77
$ 4.97 x 100
$ 0.00 x 0
$ 4.77 - $ 4.77
$ 3.90 - $ 55.00
168,683
na
153.49M
$ -3.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...